Valcare Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 34

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 6

Valcare General Information

Description

Developer of a transcatheter technology designed to offer treatment for mitral and tricuspid regurgitation. The company's technology serves as a docking station for replacement prostheses and a tool for mitral annulus repair, enabling patients with heart disorders to get advanced treatment and recover faster.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • PO Box 12268
  • Maskit 2, Herzlyia Pituach
  • Herzliya 4673301
  • Israel
+972
Primary Industry
Therapeutic Devices
Vertical(s)
Corporate Office
  • PO Box 12268
  • Maskit 2, Herzlyia Pituach
  • Herzliya 4673301
  • Israel
+972

Valcare Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Valcare Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Secondary Transaction - Private 01-Aug-2023 Completed Generating Revenue
6. Later Stage VC 28-Jul-2022 Completed Generating Revenue
5. Later Stage VC (Series D) 22-Jul-2021 Completed Generating Revenue
4. Later Stage VC (Series D) 01-Sep-2018 Completed Generating Revenue
3. Later Stage VC (Series C) 19-Jun-2017 Completed Generating Revenue
2. Early Stage VC (Series A) 29-Jun-2012 $8M $14M Completed Startup
1. Early Stage VC $6M $6M Completed Startup
To view Valcare’s complete valuation and funding history, request access »

Valcare Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D
Series C
Series B 4,111,000 $0.000100 6% $1.46 $1.46 1x $0.32 7.97%
Series A 6,667,731 $0.000100 6% $1.46 $1.46 1x $0.32 12.92%
To view Valcare’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Valcare Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a transcatheter technology designed to offer treatment for mitral and tricuspid regurgitation. The company'
Therapeutic Devices
Herzliya, Israel
34 As of 2024

Irvine, CA
 

Milan, Italy
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Valcare Competitors (20)

One of Valcare’s 20 competitors is JenaValve Technology, a Pending Transaction (M&A) company based in Irvine, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
JenaValve Technology Pending Transaction (M&A) Irvine, CA
InnovHeart Venture Capital-Backed Milan, Italy
MitrAssist Private Equity-Backed Caesarea, Israel
Coramaze Technologies Venture Capital-Backed Tel Aviv, Israel
HighLife Venture Capital-Backed Paris, France
You’re viewing 5 of 20 competitors. Get the full list »

Valcare Patents

Valcare Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230372086-A1 Systems and methods preventing paravalvular leak (pvl) associated with a replacement structural cardiac valve Pending 23-May-2022
EP-3982844-A1 Systems and methods for delivery of chordae replacement system Inactive 11-Jun-2019
EP-3982844-A4 Systems and methods for delivery of chordae replacement system Inactive 11-Jun-2019
EP-3525864-B1 Device for delivery of an implant through a catheter Active 11-Oct-2016
EP-3525864-A4 Device and method for delivery of an implant through a catheter Active 11-Oct-2016 A61F2/2436
To view Valcare’s complete patent history, request access »

Valcare Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Valcare Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Techwald Holding Venture Capital Minority
BioStar Capital Venture Capital Minority
HBM Partners Venture Capital Minority
MicroPort CardioFlow Corporation Minority
Arkin Capital Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Valcare FAQs

  • When was Valcare founded?

    Valcare was founded in 2012.

  • Where is Valcare headquartered?

    Valcare is headquartered in Herzliya, Israel.

  • What is the size of Valcare?

    Valcare has 34 total employees.

  • What industry is Valcare in?

    Valcare’s primary industry is Therapeutic Devices.

  • Is Valcare a private or public company?

    Valcare is a Private company.

  • What is Valcare’s current revenue?

    The current revenue for Valcare is .

  • How much funding has Valcare raised over time?

    Valcare has raised $44.3M.

  • Who are Valcare’s investors?

    Techwald Holding, BioStar Capital, HBM Partners, MicroPort CardioFlow, and Arkin Capital are 5 of 6 investors who have invested in Valcare.

  • Who are Valcare’s competitors?

    JenaValve Technology, InnovHeart, MitrAssist, Coramaze Technologies, and HighLife are some of the 20 competitors of Valcare.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »